Magnetic resonance imaging in the diagnosis of breast cancer metastases in the brain (a brief review of the literature)

Author:

Panshin G. A.1ORCID,Nudnov N. V.1ORCID

Affiliation:

1. Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation

Abstract

Breast cancer occupies the 1st place in the structure of oncological morbidity and mortality in the female population in the Russian Federation and is the second most common metastasis of primary solid malignant tumor after lung cancer, and the incidence of these often fatal lesions is currently increasing after improving systemic treatment.At the same time, the prognosis of patients who develop metastatic brain damage is usually unfavorable, since few of them live longer than 1 year.The purpose of the study: to analyze recent studies related to the use of magnetic resonance imaging in the diagnosis of breast cancer metastases in the brain.Conclusion. If there are characteristic results of MRI studies indicating the presence of possible primary gliomas of the brain, and not metastases, surgical intervention (biopsy) is necessary for histopathological studies, in order to finally establish the diagnosis of the underlying disease.

Publisher

Vidar, Ltd.

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference60 articles.

1. Kaprin A.D., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow: P. Hertsen Moscow oncology research institute – Branch of National Medical Research Radiological Centre of the Ministry of Healthcare of the Russian Federation. 2019. 250 p. ISBN 978-5-85502-251-3. https://oncology-association.ru/wp-content/uploads/2020/09/2018.pdf (In Russian)

2. Dawood S., Gonzalez-Angulo A.M., Albarracin C. et al. Woodward WA. Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review. Cancer. 2010; 116 (13): 3084–3092. http://doi.org/10.1002/cncr.25115

3. Niikura N., Hayashi N., Masuda N. et al. Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis. Breast Cancer Res. Treat. 2014; 147 (1): 103–112. http://doi.org/10.1007/s10549-014-3090-8

4. Jang G., Lee S.S., Ahn J.H. et al. Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea. Breast Cancer Res. Treat. 2011; 128 (1): 171–177. http://doi.org/10.1007/s10549-011-1526-y

5. Cho S.Y., Choi H.Y. Causes of death and metastatic patterns in patients with mammary cancer. Ten-year autopsy study. Am. J. Clin. Pathol. 1980; 73 (2): 232–234. http://doi.org/10.1093/ajcp/73.2.232

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3